Construction of E2F-1 gene eukaryotic expression vector and selection of Genectin-resistant gastric carcinoma cells
Xie Yu
Abstract
Xie Yu
Abstract
Objective To construct an eukaryotic expression vector containing E2F-1 gene and transfect the vector into gastric cancer cell line MGC-803.Methods Total RNA was extracted from normal human liver.E2F-1 cDNA was cloned by using RT-PCR method and transferred into eukaryotic expression vector pCMV-HA2 after digested by restrictive endonuclease enzyme Hind Ⅲ and EcoRⅠ.Then pCMV-E2F-1-HA2 was transfected into MGC-803 cells with Lipofectamine 2000.The genectin-resistant cells were selected and harvested in medium containing G418.RT-PCR and Western blot were used to identify the expression of E2F-1.Results pCMV-E2F-1-HA2 prospective fragments was obtained and the result of sequencing was completely consistent with the reported E2F-1 gene sequences.Cell clones with resistance to Genetecin were obtained and amplified.Experimental results of RT-PCR and Western blot confirmed that the recombinant vector pCMV-E2F-1-HA2 was successfully transfected into gastric cancer cell line MGC-803 and stably overexpressed the E2F-1 gene.Conclusion Eukaryotic expression vector pCMV-E2F-1-HA2 had been successfully constructed.Gastric cancer cell line MGC-803/E2F-1 with stable overexpression of the E2F-1 gene was established.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To construct an eukaryotic expression vector containing E2F-1 gene and transfect the vector into gastric cancer cell line MGC-803.Methods Total RNA was extracted from normal human liver.E2F-1 cDNA was cloned by using RT-PCR method and transferred into eukaryotic expression vector pCMV-HA2 after digested by restrictive endonuclease enzyme Hind Ⅲ and EcoRⅠ.Then pCMV-E2F-1-HA2 was transfected into MGC-803 cells with Lipofectamine 2000.The genectin-resistant cells were selected and harvested in medium containing G418.RT-PCR and Western blot were used to identify the expression of E2F-1.Results pCMV-E2F-1-HA2 prospective fragments was obtained and the result of sequencing was completely consistent with the reported E2F-1 gene sequences.Cell clones with resistance to Genetecin were obtained and amplified.Experimental results of RT-PCR and Western blot confirmed that the recombinant vector pCMV-E2F-1-HA2 was successfully transfected into gastric cancer cell line MGC-803 and stably overexpressed the E2F-1 gene.Conclusion Eukaryotic expression vector pCMV-E2F-1-HA2 had been successfully constructed.Gastric cancer cell line MGC-803/E2F-1 with stable overexpression of the E2F-1 gene was established.
Key concepts: Lipofectamine, Transfection, Biology, Molecular biology, Complementary DNA, E2F, Gene, Expression vector